Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids
British Journal of Ophthalmology Apr 26, 2018
Nakayama M, et al. - Authors ascertained the clinical features, treatment and visual outcomes of Japanese patients with new-onset acute Vogt-Koyanagi-Harada (VKH) disease. A presentation of serous retinal detachment and optic disc hyperaemia was seen. Findings suggested that 93.8% of the tested patients were human leucocyte antigen-DR4 positive and 81.8% had cerebrospinal fluid pleocytosis. In 49.5% of eyes, sunset glow fundus was observed and in 22.5% anterior and/or posterior segment recurrence of inflammation was observed. Ocular complications, mostly cataract, were observed in 21.2% and systemic complications, mostly hypertension and diabetes mellitus, were observed in 8.1% of patients. As per data, in a large number of patients with new-onset acute VKH disease, with transitioning to cyclosporine in selected cases an aggressive corticosteroid treatment strategy resulted in excellent visual outcomes and low rates of recurrence.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries